Correct diagnostic classification and treatment of pneumonia symptoms in under-five children, northwest Ethiopia: a cross-sectional study
Abstract
Introduction Despite Ethiopia’s adoption of the Integrated Management of Newborn and Childhood Illnesses (IMNCI) strategy, pneumonia continues to be the leading infectious cause of death among under-five children. Therefore, this study aimed to determine the proportion of under-five children who had received the accurate diagnostic classification and appropriate treatment for symptoms of pneumonia using the IMNCI guideline and to identify factors associated with guideline adherence. Methods A cross-sectional study was conducted between March and July 2023 among sick under-five children who visited health centres in the South Gondar zone, northwest Ethiopia. We employed two-stage random sampling. Observation of healthcare providers’ clinical assessment, diagnosis and treatment; re-assessing children; interviewing caregivers and healthcare providers; and facility audit were applied to collect the data. Both descriptive and multilevel binary logistic regression analyses were done. Results Only 35.6% (95% CI: 33.2, 38.0) of sick children with pneumonia symptoms received the correct classification and treatment. Factors associated with accurate diagnostic classification and appropriate treatment included being a young infant (adjusted OR (AOR): 2.8, 95% CI: 1.4, 5.4), absence of fever (AOR: 1.5, 95% CI: 1.1, 2.0), longer consultation times (AOR: 1.4, 95% CI: 1.1, 1.9), receiving care from healthcare providers who referred to the chart booklet during diagnosis and treatment (AOR:…
Read the paper
Related studies
- Severe clinical outcomes of COVID-19 associated with proton pump inhibitors: a nationwide cohort study with propensity score matching
- Levofloxacin-Induced Tendon Rupture: A Case Report and Review of the Literature
- Association between cord blood 25-hydroxyvitamin D concentrations and respiratory tract infections in the first 6 months of age in a Korean population: a birth cohort study (COCOA)
- Neuroprotective Effects of Epicatechin against Oxidative Stress-Induced Cognitive Impairment: A Systematic Review and Meta-Analysis
- Quality evaluation and in vitro interaction studies between levofloxacin 250mg and diclofenac sodium 50mg tablets
- Molecular Epidemiology of mcr-1 -Positive Polymyxin B-Resistant Escherichia coli Producing Extended-Spectrum β-Lactamase (ESBL) in a Tertiary Hospital in Shandong, China
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.